United States · Series E startup
10 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$99Mraised across 10 rounds since 2009, from 10 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by sec.gov
No investor was named in the report.
From a historical funding recordSEC filing: $28M sold, first sale Oct 2012
Reported by in.finance.yahoo.comSEC filing: $17M sold, first sale Oct 2012
No investor was named in the report.
Reported by sec.govSEC filing: $3.0M sold, first sale Dec 2011
Reported by onbiovc.comSEC filing: $14M sold, first sale Jun 2007
No investor was named in the report.
From a historical funding recordSEC filing: $14M sold, first sale Jun 2007
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Jan 2010
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Oct 2009
No investor was named in the report.
From a historical funding recordSEC filing: $3.0M sold, first sale May 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
CMEA Ventures
Thomas, McNerney & Partners
Panorama CapitalSloan Biotech Funds
Deerfield
Oxford Finance LLCBioMed VenturesFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Auspex Pharmaceuticals's investors include CMEA Ventures, Thomas, McNerney & Partners, Panorama Capital, Sloan Biotech Funds and Deerfield, and 2 more on record.
Auspex Pharmaceuticals has raised $99M across 10 rounds since 2009.
Auspex Pharmaceuticals's most recent round was a Series E of $20M in Jan 2014.
Auspex Pharmaceuticals's largest round on record is $25M (Series D), in Nov 2012.
Auspex Pharmaceuticals's first round on record, in Oct 2010, was backed by CMEA Ventures, Thomas, McNerney & Partners and Sloan Biotech Funds.
Auspex Pharmaceuticals's latest named round is a Series E, in Jan 2014.
Auspex Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·